These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2741306)

  • 1. Influence of T-2 toxin on BCG vaccine efficacy against murine pulmonary tuberculosis.
    Ziprin RL; McMurray DN
    Vet Hum Toxicol; 1989 Jun; 31(3):213-7. PubMed ID: 2741306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
    Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
    J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effect of T-2 toxin on murine host resistance to three facultative intracellular bacterial pathogens: Listeria monocytogenes, Salmonella typhimurium, and Mycobacterium bovis.
    Ziprin RL; McMurray DN
    Am J Vet Res; 1988 Jul; 49(7):1188-92. PubMed ID: 3138932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium bovis BCG vaccination modulates TNF-alpha production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs.
    Yamamoto T; Lasco TM; Uchida K; Goto Y; Jeevan A; McFarland C; Ly L; Yamamoto S; McMurray DN
    Tuberculosis (Edinb); 2007 Mar; 87(2):155-65. PubMed ID: 17289434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Protective efficacy of BCG Tokyo 172 in the guinea pig model of pulmonary tuberculosis].
    Yamamoto T; Phalen S; Uchida K; Umemori K; Nojima Y; Horiuchi Y; Goto Y; McMurray DN; Yamamoto S
    Kekkaku; 2000 May; 75(5):379-88. PubMed ID: 10853313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis.
    Aldwell FE; Cross ML; Fitzpatrick CE; Lambeth MR; de Lisle GW; Buddle BM
    Vaccine; 2006 Mar; 24(12):2071-8. PubMed ID: 16332403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the protective efficacy of bacille calmette-Guérin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis.
    Williams A; Davies A; Marsh PD; Chambers MA; Hewinson RG
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S299-301. PubMed ID: 10875804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of remaining live BCG organisms in vaccinated mice on the maintenance of immunity to tuberculosis.
    Olsen AW; Brandt L; Agger EM; van Pinxteren LA; Andersen P
    Scand J Immunol; 2004 Sep; 60(3):273-7. PubMed ID: 15320884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study of the protective effect of the DNA vaccine encoding tubercle antigen 85B with MPT64 in mice challenged with Mycobacterium tuberculosis].
    Luo XD; Zhu DY; Chen Q; Jiang Y; Jiang S; Yang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Sep; 27(9):611-6. PubMed ID: 15498274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice.
    Giri PK; Verma I; Khuller GK
    J Infect; 2006 Nov; 53(5):350-6. PubMed ID: 16442629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal boost with adjuvanted heat-killed BCG or arabinomannan-protein conjugate improves primary BCG-induced protection in C57BL/6 mice.
    Haile M; Hamasur B; Jaxmar T; Gavier-Widen D; Chambers MA; Sanchez B; Schröder U; Källenius G; Svenson SB; Pawlowski A
    Tuberculosis (Edinb); 2005; 85(1-2):107-14. PubMed ID: 15687034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The estimation of protective efficacy of the fusion gene vaccine encoding tubercle antigen 85B and MPT64 in mice challenged with Mycobacterium tuberculosis].
    Luo XD; Zhu DY; Jiang S; Chen Q; Jiang Y
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(8):687-91. PubMed ID: 15130316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new vaccine against tuberculosis shows greater protection in a mouse model with progressive pulmonary tuberculosis.
    Castañon-Arreola M; López-Vidal Y; Espitia-Pinzón C; Hernández-Pando R
    Tuberculosis (Edinb); 2005; 85(1-2):115-26. PubMed ID: 15687035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased protection against bovine tuberculosis in the brushtail possum (Trichosurus vulpecula) when BCG is administered with killed Mycobacterium vaccae.
    Skinner MA; Keen DL; Parlane NA; Yates GF; Buddle BM
    Tuberculosis (Edinb); 2002; 82(1):15-22. PubMed ID: 11914058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against an aerogenic Mycobacterium tuberculosis infection in BCG-immunized and DNA-vaccinated mice is associated with early type I cytokine responses.
    Goter-Robinson C; Derrick SC; Yang AL; Jeon BY; Morris SL
    Vaccine; 2006 Apr; 24(17):3522-9. PubMed ID: 16519971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
    Mollenkopf HJ; Kursar M; Kaufmann SH
    J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and protection induced by Mycobacterium tuberculosis mce-2 and mce-3 mutants in a Balb/c mouse model of progressive pulmonary tuberculosis.
    Aguilar LD; Infante E; Bianco MV; Cataldi A; Bigi F; Pando RH
    Vaccine; 2006 Mar; 24(13):2333-42. PubMed ID: 16388878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consequence of prior exposure to environmental mycobacteria on BCG vaccination and diagnosis of tuberculosis infection.
    Thom M; Howard C; Villarreal-Ramos B; Mead E; Vordermeier M; Hope J
    Tuberculosis (Edinb); 2008 Jul; 88(4):324-34. PubMed ID: 18329343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.